Nocturnal Parkinson's Disease Symptoms Study Group

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

Roongroj Bhidayasiri, Chulalongkorn University

ClinicalTrials.gov Identifier:

NCT01662427

First received: August 7, 2012

Last updated: August 18, 2013

Last verified: August 2013

History of Changes

Purpose

To study associate factor of Noctural Parkinson's Disease Symptoms and quality of life in Parkinson's disease patients and caregivers.

Condition	Intervention
Parkinson's Disease	Other: Questionaire to assess Noctural Parkinson's Disease Symptoms


Study Type:	Observational
Study Design:	Observational Model: Cohort Time Perspective: Prospective
Official Title:	Nocturnal Parkinson's Disease Symptoms Study Group

Resource links provided by NLM:

Genetics Home Reference related topics: Parkinson disease

MedlinePlus related topics: Parkinson's Disease

U.S. FDA Resources

Further study details as provided by Roongroj Bhidayasiri, Chulalongkorn University:

Primary Outcome Measures:

To assess Noctural Parkinson's Disease Symptoms

Secondary Outcome Measures:

To assess quality of life in Parkinson's Disease patient
To assess quality of life in caregiver of Parkinson's Disease patient


Enrollment:	300
Study Start Date:	November 2012
Study Completion Date:	August 2013
Primary Completion Date:	August 2013 (Final data collection date for primary outcome measure)

Groups/Cohorts	Assigned Interventions
Questionniare	Other: Questionaire to assess Noctural Parkinson's Disease Symptoms Questionaire to assess Noctural Parkinson's Disease Symptoms and quality of life

Eligibility


Ages Eligible for Study:	30 Years to 90 Years (Adult, Senior)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	Yes
Sampling Method:	Probability Sample

Study Population

Parkinson's disease patient and care givers

Criteria

Inclusion Criteria:

Idiopathic Parkinson's disease patient

Exclusion Criteria:

Patient with Secondary Parkinsonism eg.Drug-induced Parkinsonism, Vascular Parkinsonism, exposure to toxin, Encephalitis
Patient with Atypical Parkinsonial Syndromes eg. Parkinson-plus syndrome, Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration (CBD)
Patient with Heredodegenerative parkinsonism eg. Spinocerebellar ataxias, Wilson's disease, Juvenile Huntington's disease

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01662427

Locations


Thailand
Roongroj Bhidayasiri
Pathumwan, Bangkok, Thailand, 10330

Sponsors and Collaborators

Chulalongkorn University

More Information


Responsible Party:	Roongroj Bhidayasiri, Associate Professor, Chulalongkorn University
ClinicalTrials.gov Identifier:	NCT01662427 History of Changes
Other Study ID Numbers:	6222012
Study First Received:	August 7, 2012
Last Updated:	August 18, 2013

Keywords provided by Roongroj Bhidayasiri, Chulalongkorn University:


Quality of life Noctural Parkinson's Disease Symptoms

Additional relevant MeSH terms:


Parkinson Disease Parkinsonian Disorders Basal Ganglia Diseases Brain Diseases	Central Nervous System Diseases Nervous System Diseases Movement Disorders Neurodegenerative Diseases

ClinicalTrials.gov processed this record on July 21, 2017

To Top